Literature DB >> 1325759

Reversible mitochondrial myopathy with cytochrome c oxidase deficiency.

M K Salo1, J Rapola, H Somer, H Pihko, M Koivikko, H J Tritschler, S DiMauro.   

Abstract

Two siblings, a boy and a girl born in a nonconsanguineous marriage, presented with a similar clinical course. Sucking and breathing difficulties appeared within a few weeks of birth. Clinical examination revealed profound muscular hypotonia, hepatomegaly, increased serum creatine kinase activities, and lactic acidosis. Both infants were treated with gavage feeding, the boy also needing ventilatory support. Clinically they improved gradually. Now, the boy aged 4 years and the girl aged 28 months are free of clinical signs. Muscle biopsy specimens taken at 3 months showed, in both, ragged red fibres, abnormal mitochondria, and reduced cytochrome c oxidase (COX) staining. Biochemical analysis showed COX activity to be reduced to about 25% of the normal mean. The second biopsy specimen from the boy at 16 months was normal on morphological examination, but the girl's second specimen at 13 months still showed abnormal features. These cases are examples of the rare benign reversible COX deficiency. Early diagnosis is crucial to provide intensive treatment until spontaneous clinical improvement appears.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325759      PMCID: PMC1793596          DOI: 10.1136/adc.67.8.1033

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Benign reversible muscle cytochrome c oxidase deficiency: a second case.

Authors:  M Zeviani; P Peterson; S Servidei; E Bonilla; S DiMauro
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

2.  Isolation and properties of cytochrome c oxidase from rat liver and quantification of immunological differences between isozymes from various rat tissues with subunit-specific antisera.

Authors:  L Kuhn-Nentwig; B Kadenbach
Journal:  Eur J Biochem       Date:  1985-05-15

3.  Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle.

Authors:  N Bresolin; M Zeviani; E Bonilla; R H Miller; R W Leech; S Shanske; M Nakagawa; S DiMauro
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

4.  Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach.

Authors:  H J Tritschler; E Bonilla; A Lombes; F Andreetta; S Servidei; B Schneyder; A F Miranda; E A Schon; B Kadenbach; S DiMauro
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

5.  Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency.

Authors:  S DiMauro; J F Nicholson; A P Hays; A B Eastwood; A Papadimitriou; R Koenigsberger; D C DeVivo
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

Review 6.  Mitochondrial diseases.

Authors:  M Zeviani; E Bonilla; D C DeVivo; S DiMauro
Journal:  Neurol Clin       Date:  1989-02       Impact factor: 3.806

  6 in total
  7 in total

1.  Benign mitochondrial encephalomyopathy in a patient with complex I deficiency.

Authors:  J M Trijbels; W Ruitenbeek; R C Sengers; A J Janssen; B A van Oost
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Expression of oxidative phosphorylation genes in muscle cell cultures from patients with mitochondrial myopathies.

Authors:  J M Collombet; H Faure-Vigny; G Mandon; R Dumoulin; S Boissier; A Bernard; B Mousson; G Stepien
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

Review 3.  Reversible infantile mitochondrial diseases.

Authors:  Veronika Boczonadi; Boglarka Bansagi; Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2014-11-19       Impact factor: 4.982

4.  Immunohistochemical analysis of muscle cytochrome c oxidase deficiency in children.

Authors:  S Possekel; A Lombes; H Ogier de Baulny; M A Cheval; M Fardeau; B Kadenbach; N B Romero
Journal:  Histochem Cell Biol       Date:  1995-01       Impact factor: 4.304

5.  Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease.

Authors:  J Uusimaa; H Jungbluth; C Fratter; G Crisponi; L Feng; M Zeviani; I Hughes; E P Treacy; J Birks; G K Brown; C A Sewry; M McDermott; F Muntoni; J Poulton
Journal:  J Med Genet       Date:  2011-10       Impact factor: 6.318

6.  Non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine inhibit cytochrome C oxidase in mouse brain regions.

Authors:  Emilio L Streck; Gabriela K Ferreira; Giselli Scaini; Gislaine T Rezin; Cinara L Gonçalves; Isabela C Jeremias; Alexandra I Zugno; Gustavo C Ferreira; Jeverson Moreira; Celine M Fochesato; Pedro R T Romão
Journal:  Neurochem Res       Date:  2011-03-02       Impact factor: 4.414

7.  Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy.

Authors:  Rita Horvath; John P Kemp; Helen A L Tuppen; Gavin Hudson; Anders Oldfors; Suely K N Marie; Ali-Reza Moslemi; Serenella Servidei; Elisabeth Holme; Sara Shanske; Gittan Kollberg; Parul Jayakar; Angela Pyle; Harold M Marks; Elke Holinski-Feder; Mena Scavina; Maggie C Walter; Jorida Coku; Andrea Günther-Scholz; Paul M Smith; Robert McFarland; Zofia M A Chrzanowska-Lightowlers; Robert N Lightowlers; Michio Hirano; Hanns Lochmüller; Robert W Taylor; Patrick F Chinnery; Mar Tulinius; Salvatore DiMauro
Journal:  Brain       Date:  2009-08-31       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.